Genetic variants associated with insulin resistance and metabolic syndrome in young Asian Indians with myocardial infarction

Metabolic Syndrome and Related Disorders

Volumn 6, Issue 3, 2008, Pages 209-214

  Ranjith, Naresh ^a   Pegoraro, Rosemary J ^b   Naidoo, Datshana P ^c   Shanmugam, Rebecca ^d   Rom, Lee ^b  

^a RK Khan Hospital   (South Africa)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c INKOSI ALBERT LUTHULI CENTRAL HOSPITAL   (South Africa)

^d SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEART INFARCTION; ADULT; ALLELE; ARTICLE; ASIAN; CONTROLLED STUDY; DNA POLYMORPHISM; EDUCATION PROGRAM; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INDIAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POPULATION; PREVALENCE; PRIORITY JOURNAL;

ADULT; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; POTASSIUM CHANNELS, INWARDLY RECTIFYING; PPAR GAMMA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 51349134000     PISSN: 15404196     EISSN: None     Source Type: Journal    
DOI: 10.1089/met.2008.0023     Document Type: Article

References (32)

1. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, Taskinen MR, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-689.
2. Girman CJ, Rhodes T, Mercuri M, Pyorälä K, Kjekshus J, Pedersen TR, Beere PA, Gotto AM, Clearfield M, 4S Group and the AFCAPS/TexCAPS Research Group. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study [4S] and the Air Force/Texas Coronary Atherosclerosis Prevention Study [AFCAPS/TexCAPS]. Am J Cardiol 2004;93:136-141.
3. Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease and all causes in United States adults. Circulation 2004;110:1245-1250.
4. Chandalia M, Abate N, Garg A, Stray-Gundersen J, Grundy SM. Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. J Clin Endocrinol Metab 1999;84:2329-2335.
5. Chadha SL, Radhakrishnan S, Ramachandran K, Kaul U, Gopinath N. Epidemiological study of coronary heart disease in urban population of Delhi. Indian J Med Res 1990;92:424-430.
6. McGettrick A. J, Feener E. P, Kahn C. R. Human IRS-1 polymorphism, G972R, causes IRS-1 to associate with the insulin receptor and inhibit receptor autophosphorylation. J Biol Chem 2004;280:6441-6446.
7. Nielsen E. M, Hansen L, Carstensen B, Echwals S. M, Drivsholm T, Glümer C, Thorsteinsson B, Borch-Johnse K, Hanse T, Pedersen O. The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes. Diabetes 2003 52:573-577.
8. Dalziel B, Gosby A. K, Richman R. M, Bryson J. M, Caterson I. D. Association of the TNF-alpha - 308 G/A promoter polymorphism with insulin resistance in obesity. Obes Res 2002:10:401-407.
9. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, Lane CR, Schaffner SF, Bolk S, Brewer C, Tuomi T, Gaudet D, Hudson TJ, Daly M, Groop L, Lander ES. The common PPAR-gamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 2000;26:76-80.
10. Hara K, Okada T, Tobe K, Yasuda Y, Mori H, Kadowaki R, Hagura Y, Akanuma S, Kimura C, Ito, Kadowaki T. The Prol2Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes. Biochem Biophys Res Commun 2000;271:212-216.
11. Mancini F. P, Vaccaro O, Sabatino L, Tufano A, Rivellese A. A, Riccardi G, Colantuoni V. Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes. Diabetes 1999 48:1466-1468.
12. Ranjith N, Pegoraro R. J, Naidoo D. P. Demographic Data and Outcome of Acute Coronary Syndrome in the South African Asian Indian Population. Cardiovasc J South Africa 2005;16:48-54.
13. Ranjith N, Pegoraro R. J, Naidoo D. P, Esterhuizen T. M. Metabolic syndrome in young Asian Indian patients with myocardial infarction. Cardiovasc J South Africa 2007;18:228-232.
14. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-969.
15. NCEP Expert Panel on the Detection, Evaluation and Treatment of High Blood pressure in Adults. Executive summary of the third report of the National Cholesterol Education Program [NCEP] expert panel on detection and evaluation and treatment of high cholesterol in adults [Adult Treatment Panel III]. JAMA 2001;285:2486-2497.
16. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. April 14, 2005, http://www.idf.org/webdata/docs/ Metac_syndrome_def.pdf (accessed June 10, 2005).
17. Holland P, Abramson R, Watson R, Gelfand D. Detection of specific polymerase chain reaction products by utilizing the 5′ to 3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci USA 1991;88:7276-7280.
18. Omar MAK, Motala AA, Seedat MA, Becker P, Knight L. South African Indians show a high prevalence of diabetes mellitus and bimodality in plasma distribution. Diabetes Care 1994;17:70-73.
19. Levitt NS, Katzenellenbogen Bradshow D, Hoffman MN, Bonnici F. The prevalence and identification of risk factor for NIDDM Urban Africans in Cape Town, South Africa. Diabetes Care 1993;16:601-607.
20. Dowse GK, Gareebo H, Zimmet PZ, et al. High prevalence of NIDDM and impaired glucose tolerance in Indian, Creloe and Chinese Mauritians. Diabetes 1990;39:390-396.
21. st century Europe? Diabetes Care 2001;24:1377-1383.
22. Després JP, Couillard C, Gagnon J, Bergeron J, Leon AS, Rao DC, Skinner JS, Wilmore JH, Bouchard C. Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training and Genetics [HERITAGE] family study. Arterioscler Thromb Vasc Biol 2000;20:1932-1938.
23. WHO EXPERT Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157-163.
24. Kahn R, Buse J, Ferrannini E, Stern M, American Diabetes Association, European Association for the Study of Diabetes. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005;28:2289-2304.
25. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991;337:382-386.
26. Abate N, Carulli L, Cabo-Chan A, Chandalia M, Snell PG, Grundy SM. Genetic polymorphism PC-1 K121Q and ethnic susceptibility to insulin resistance. J Clin Endocrinol Metab 2003;88:5927-5934.
27. Radha V, Vimaleswaran KS, Babu HNS, Abate N, Chandalia M, Satija P, Grundy SM, Ghosh S, Majumder PP, Deepa R, Rao SMR, Mohan V. Role of genetic polymorphism peroxisome proliferator-activated receptor-γ2 Pro12Ala on ethnic susceptibility to diabetes in South-Asian and Caucasian subjects. Diabetes Care 2006;29:1046-1051.
28. Walston J, Seibert M, Jen-Yen, Cheskin L, Andersen R. Tumor necrosis factor-alpha-238 and -308 polymorphisms do not associate with traits related to obesity and insulin resistance. Diabetes 1999;48:2096-2098.
29. Sookoian SC, Gonzalez C, Pirola CJ. Meta-analysis on the G-308A tumor necrosis factor α gene variant and phenotypes associated with the metabolic syndrome. Obesity Res 2005;13:2122-2131.
30. + channel genes KCNJ11 [Kir6.2] and ABCC8 [SUR1] in relation to glucose intolerance: population-based studies and meta-analyses. Diabetes Med 2005;22:590-598.
31. Baroni M. G, Arca M, Sentinelli F, Buzzetti R, Capici F, Lovari S, Vitale M, Romeo S, Di Mario U. The G972R variant of the insulin receptor substrate-1 [IRS-1] gene, body fat distribution and insulin-resistance. Diabetologia 2001;44:367-372.
32. Yang W. S, Hsiung C. A, Ho L. T, Chen Y. T, He C. T, Curb J. D, Grove J, Quertermous T, Chen Y. D, Kuo S. S, Chuang L. M. Genetic epistasis of adiponectin and PPARgamma2 genotypes in modulation of insulin sensitivity: a family-based association study. Diabetologia 2003;46:977-983.